Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

UNITAID - Financed Project to Increase Access to New HIV Monitoring Technology

Published: Thursday, February 14, 2013
Last Updated: Wednesday, February 13, 2013
Bookmark and Share
Agreement signed with FEI to improve HIV monitoring through affordable access to viral load testing for HIV patients and early infant diagnosis in resource-limited settings.

UNITAID and France Expertise Internationale (FEI) have signed a US$ 2.4 million agreement to implement the “OPP-ERA” project which will stimulate the market entry of new manufacturers and suppliers of HIV Viral Load Test (VLT) technologies, bringing an innovative solution to meet the HIV monitoring and diagnostics needs in resource-limited settings.

OPP-ERA - OPP standing for Open Polyvalent Platforms - is an innovative system to detect HIV viral load, which enables machines and reagents coming from different manufacturers and suppliers to be used together.

This diagnostic system is flexible, rapid, and easy to use, with appropriate-sized machines for peripheral settings.

The OPP system can be used not only for HIV viral load testing and early infant diagnosis, but also for other infectious agents.

This initiative aims to bring the prices of these tests down.

OPP-ERA will focus on viral load testing for adults and early infant diagnosis of HIV. Viral load testing is crucial to determine when patients need to switch treatments.

Currently, less than 10% of HIV patients in low-income settings have access to viral load tests as they are expensive and usually only available in the central laboratories of capitals.

Early infant diagnosis is essential for young infants born to mothers living with HIV. In 2011 alone, 230,000 children died of AIDS-related causes, most before the age of two. These deaths could have been avoided by making an accurate diagnosis followed by adapted treatment in the first weeks of life.

UNITAID will finance OPP-ERA for an initial pilot stage in 4 countries: Burundi, Cameroon, Côte d’Ivoire, and Guinea. The project will be implemented by a consortium of partners led by FEI, comprising the French National Agency for Research on AIDS and Viral Hepatitis (ANRS), the Network for Therapeutic Solidarity in Hospitals (ESTHER), SIDACTION and Therapeutic Solidarity and Initiatives against AIDS (SOLTHIS).

FEI is a French governmental agency for international cooperation and development under the supervision of the French Ministry of Foreign and European Affairs.

OPP-ERA is a key part of UNITAID’s investment to bring vital HIV monitoring and testing to remote communities. “The UNITAID Executive Board has approved grants to the Clinton Health Access Initiative, UNICEF, Médecins Sans Frontières and FEI to introduce new diagnostics. OPP-ERA completely fits into UNITAID’s approach to provide a comprehensive response to affordable diagnostic tools in countries in need”, said Dr Denis Broun, Executive Director of UNITAID.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Unitaid Approves $30 Million for Groundbreaking Tuberculosis Test
The executive board of UNITAID approved the funding to scale up access to innovative diagnostic test for tuberculosis, Xpert MTB/RIF, and reduce the cost of its use.
Friday, June 15, 2012
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Researchers Find a Gap in the Brain’s Firewall Against Parkinson’s Disease
Researchers at NIH have found mouse study that identified a key player in the progression of the disorder.
Fat Cells That Amplify Nerve Signals in Response to Cold Also Affect Blood Sugar Metabolism
Researchers at UTSW have found that the protein connexin 43 forms cell-to-cell communication channels on the surface of emerging beige fat cells that amplify the signals from those few nerve fibers.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Faecal Bacteria Linked to Body Fat
Researchers at King’s College London have found a new link between the diversity of bacteria in human poo – known as the human faecal microbiome - and levels of abdominal body fat.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!